SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Swift who wrote (844)5/6/1998 9:19:00 AM
From: Biomaven   of 10280
 
Talking about options, the OCT 50 CALL is 4.625 and the OCT 35 CALL is 14.625. Now if I write a covered contract of OCT 50 CALL and buy a contract of OCT 35 CALL, I will for sure make $5/share while still keeping the same number of shares. Sort of eating my cake and keeping it. Am I missing something ?

There is usually no free cake to be had. :(

In your example, you would lose on any significant decline in price. For example, if in October the stock closed at $35 or below, you would be out $10 on your options (the difference between what you paid for your OCT 35 calls and what you received for your OCT 50 contracts). This is true whether or not you actually own the underlying shares.

On the comparison with ENMD:
ENMD was a freak event (for which I was duly grateful) caused by huge media publicity. What ENMD stock did is totally unrelated to SEPR and its valuation, other than if it draws renewed speculative attention to biotechs (which may or may not be good, but which will certainly make things more interesting).

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext